Key points from article :
Pharmaceuticals companies analysings hundreds of thousands of DNA samples to identify new gene targets. Previously took decades to find and study enough people with rare traits.
Join the club for FREE to access the whole archive and other member benefits.
Key points from article :
Pharmaceuticals companies analysings hundreds of thousands of DNA samples to identify new gene targets. Previously took decades to find and study enough people with rare traits.
Click on resource name for more details.
Founder and director of the Scripps Research Translational Institute, American cardiologist, scientist and author